Esperion Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 02/13/2025 | 24.48 M | $53.86 M | 4.87% | 12.56% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 14.24 M | $31.32 M | -0.21% | 7.30% |
| VANGUARD GROUP INC | 02/11/2025 | 11.72 M | $25.77 M | -10.18% | 6.01% |
| BELLEVUE GROUP AG | 02/14/2025 | 9.94 M | $21.88 M | 0.00% | 5.10% |
| TWO SEAS CAPITAL LP | 02/18/2025 | 6.23 M | $13.71 M | -5.37% | 3.20% |
| STATE STREET CORP | 02/14/2025 | 4.50 M | $9.91 M | 16.86% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 4.34 M | $9.55 M | 0.20% | 2.23% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 3.62 M | $7.96 M | 0.45% | 1.86% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 3.54 M | $7.79 M | -2.34% | 1.82% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 3.12 M | $6.86 M | 48.61% | 1.60% |
| INDABA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 3.00 M | $6.60 M | 100.00% | 1.54% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.75 M | $6.06 M | 110.55% | 1.41% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.45 M | $5.40 M | 18.61% | 1.26% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 1.92 M | $4.21 M | -3.04% | 0.98% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.50 M | $3.31 M | -33.00% | 0.77% |
| CENTERBOOK PARTNERS LP | 02/13/2025 | 1.31 M | $2.87 M | -58.03% | 0.67% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 932,008 | $2.05 M | 31.03% | 0.48% |
| UBS GROUP AG | 02/14/2025 | 876,942 | $1.93 M | 871.22% | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 840,052 | $1.85 M | -23.13% | 0.43% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 829,885 | $1.83 M | -75.62% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 728,232 | $1.60 M | -3.68% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 578,800 | $1.27 M | -36.68% | 0.30% |
| HRT FINANCIAL LP | 02/14/2025 | 560,545 | $1.23 M | 100.00% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 560,276 | $1.23 M | -7.08% | 0.29% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 554,216 | $1.22 M | -0.13% | 0.28% |
| WALLEYE TRADING LLC | 02/13/2025 | 529,300 | $1.16 M | 0.78% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 483,700 | $1.06 M | 12.18% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 427,532 | $940,572 | 0.41% | 0.22% |
| BARCLAYS PLC | 02/13/2025 | 359,235 | $791,000 | 16.01% | 0.18% |
| DIAMETRIC CAPITAL, LP | 02/12/2025 | 354,010 | $778,822 | -46.91% | 0.18% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 339,032 | $745,870 | 61.27% | 0.17% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 323,800 | $712,360 | -12.20% | 0.17% |
| HEADLANDS TECHNOLOGIES LLC | 02/12/2025 | 255,066 | $561,145 | 55.01% | 0.13% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 02/12/2025 | 254,265 | $559,383 | 0.00% | 0.13% |
| JANE STREET GROUP, LLC | 02/14/2025 | 253,000 | $556,600 | 635.47% | 0.13% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 251,592 | $553,502 | 152.67% | 0.13% |
| RHUMBLINE ADVISERS | 01/30/2025 | 246,914 | $543,207 | 1.57% | 0.13% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 228,730 | $503,206 | -69.53% | 0.12% |
| HAP TRADING, LLC | 02/13/2025 | 225,000 | $78,750 | 0.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 224,500 | $493,900 | -3.23% | 0.12% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 02/14/2025 | 222,482 | $489,460 | 0.00% | 0.11% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 197,919 | $435,421 | -13.70% | 0.10% |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 02/06/2025 | 195,125 | $429,275 | 0.00% | 0.10% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 192,415 | $423,313 | -19.00% | 0.10% |
| CITIGROUP INC | 02/12/2025 | 192,123 | $422,671 | 15.73% | 0.10% |
| SIGMA PLANNING CORP | 02/03/2025 | 190,441 | $418,970 | 1,455.76% | 0.10% |
| PENTWATER CAPITAL MANAGEMENT LP | 02/14/2025 | 181,290 | $398,838 | 0.00% | 0.09% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 173,083 | $380,783 | 602.82% | 0.09% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 166,220 | $365,684 | -89.35% | 0.09% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 159,260 | $350,372 | -12.55% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Esperion Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 263 institutional investors and hedge funds held shares of Esperion Therapeutics, Inc.. The most heavily invested institutionals were:
WASATCH ADVISORS LP: 24.48 M
BlackRock Funding, Inc. /DE: 14.24 M
VANGUARD GROUP INC: 11.72 M
Bellevue Group AG: 9.94 M
Two Seas Capital LP: 6.23 M
STATE STREET CORP: 4.5 M
64.65% of Esperion Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 143.72 M shares in the last 24 months. This purchase volume represents approximately $309.00 M in transactions.